Department of Anesthesiology
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H
Hemmings HC.  1998.  General anesthetic effects on protein kinase C.. Toxicol Lett. 100-101:89-95.
Hemmings HC, Adamo AI, Hoffman MM.  1995.  Biochemical characterization of the stimulatory effects of halothane and propofol on purified brain protein kinase C.. Anesth Analg. 81(6):1216-22.
Hemmings HC, Greengard P.  1986.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution.. J Neurosci. 6(5):1469-81.
Hemmings HC, Greengard P.  2010.  Positively active: how local anesthetics work.. Anesthesiology. 113(1):250-2.
Hemmings HC, Nairn AC, Aswad DW, Greengard P.  1984.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus.. J Neurosci. 4(1):99-110.
Hemmings HC, Adamo AI.  1994.  Effects of halothane and propofol on purified brain protein kinase C activation.. Anesthesiology. 81(1):147-55.
Hemmings HC.  2004.  Neuroprotection by Na+ channel blockade.. J Neurosurg Anesthesiol. 16(1):100-1.
Hemmings HC.  2022.  Turning the page on 2021: an eventful year for the British Journal of Anaesthesia.. Br J Anaesth. 128(1):1-3.
Hemmings HC, Nairn AC, Elliott JI, Greengard P.  1990.  Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity.. J Biol Chem. 265(33):20369-76.
Hemmings HC, Greengard P.  1989.  ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Purification and characterization of the protein from bovine caudate nucleus.. J Neurosci. 9(3):851-64.
Hemmings HC.  2009.  Sodium channels and the synaptic mechanisms of inhaled anaesthetics.. Br J Anaesth. 103(1):61-9.
Hemmings HC, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL.  2005.  Emerging molecular mechanisms of general anesthetic action.. Trends Pharmacol Sci. 26(10):503-10.
Hemmings HC, Jevtovic-Todorovic V.  2013.  Special issue on anaesthetic neurotoxicity and neuroplasticity.. Br J Anaesth. 110 Suppl 1:i1-2.
Hemmings, Jr. HC, Egan TD.  2019.  Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application. :994.
Hemmings HC, Hunter JM.  2017.  Landmarks in UK anaesthesia.. Br J Anaesth. 119(6):1073-1074.
Hemmings HC, Nairn AC, Greengard P.  1986.  Protein kinases and phosphoproteins in the nervous system.. Res Publ Assoc Res Nerv Ment Dis. 64:47-69.
Hemmings HC, Mantz J.  2008.  Xenon and the pharmacology of fear.. Anesthesiology. 109(6):954-5.
Heerdt PM.  2004.  Anesthesia and multiorgan protein remodeling.. Anesthesiology. 101(4):1040;authorreply1040-1.
Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, Lee DL, Oz MC, Marks AR, Burkhoff D.  2000.  Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure.. Circulation. 102(22):2713-9.
Heerdt PM, Sunaga H, Savarese JJ.  2015.  Novel neuromuscular blocking drugs and antagonists.. Curr Opin Anaesthesiol. 28(4):403-10.
Heerdt PM.  2011.  Letter to the editor: response to Ballestero et al.. Pediatr Cardiol. 32(6):866-7.
Heerdt PM.  1992.  Intrapulmonary Doppler for continuous measurement of cardiac output.. J Cardiothorac Vasc Anesth. 6(3):382-3.
Heerdt PM, The AHS, Markov NP.  2005.  Anesthetic-induced alteration in expression of myocardial calcium cycling proteins.. J Cardiothorac Vasc Anesth. 19(3):340-4.
Heerdt PM, Pleimann BE.  1996.  The dose-dependent effects of halothane on right ventricular contraction pattern and regional inotropy in swine.. Anesth Analg. 82(6):1152-8.
Heerdt PM, Caldwell RW.  1990.  The cardiovascular response to digoxin in conscious dogs with left atrial obstruction.. J Cardiothorac Anesth. 4(6):687-94.